Orgenesis Inc. (NasdaqCM:ORGS) entered into a binding Term Sheet agreement to acquire Octomera LLC from MM OS Holdings, L.P. on January 15, 2024. The transaction is subject to approval by The Board of Directors of Orgenesis.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 USD | -1.40% | -1.42% | -0.14% |
Apr. 16 | North American Morning Briefing : Powell Comments, -2- | DJ |
Apr. 15 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-0.14% | 17.27M | |
-2.33% | 187B | |
-1.74% | 106B | |
-4.32% | 66.9B | |
+0.52% | 49.45B | |
+16.18% | 48B | |
+4.06% | 40.84B | |
+3.28% | 26.48B | |
+1.12% | 26.25B | |
+12.96% | 24.62B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. entered into a binding Term Sheet agreement to acquire Octomera LLC from MM OS Holdings, L.P.